Unlike stimulant-heavy fat burners or detox teas, ColonBroom is designed for sustainable progress rather than short-term fixes
Hypersensitivity or serious allergic reactions like anaphylaxis (a severe, possibly life-threatening allergic reaction), angioedema (swelling deep in the skin) were reported in clinical trials
Gallbladder and pancreatic risks, while low in absolute terms, require monitoring, especially in patients with a history of gallstones or pancreatitis
These global trials are expected to conclude their primary collection phases in late 2026, with official FDA submissions projected for early 2027
Holistic care as an antidote to spiraling health care costs When GLP-1 medications are indicated as the best choice for achieving an individuals health goals, they should be paired with a holistic approach to wellness